Rimonabant: weight loss at risk of serious adverse events is a topic covered in the EE+ POEM Archive.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rimonabant: weight loss at risk of serious adverse events
ID - 426116
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/426116/all/Rimonabant:_weight_loss_at_risk_of_serious_adverse_events
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -